Back in April, Anthropic unveiled its Claude Mythos AI model that it said was too powerful to publicly release. Instead, the company has shared access with software vendors, including Apple, in an ...

Anthropic announced Claude Fable 5, a Mythos-class model that will be available to its enterprise customers and paid subscribers. The company unveiled Mythos in April and has limited the rollout ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science - and culture - of weight loss. Now a growing body of research is raising ...

Tesla CEO Elon Musk used to refer to the company’s electric-vehicle lineup as a “S3XY” suite of cars. But he’ll need a new moniker as Tesla does away with its Model S and Model X vehicles, which have ...

The new Claude Opus 4.8 is a "modest but tangible improvement," but a Mythos model you can use may be just weeks away. Jon covers artificial intelligence. He previously led CNET's home energy and ...

Anthropic has confirmed that it plans to bring Mythos-class models to the general public after delaying the rollout due to security risks to public and private software. Mythos was announced in April ...

BTS. The Pussycat Dolls. "Scrubs." It's en vogue these days to make a comeback. Could Tesla's recently discontinued electric cars — the Model S and Model X — eventually join the trend? Lars Moravy, ...

ASHFORD, Wash. — Mount Rainier National Park has temporarily closed part of the Wonderland Trail because of unusual bear activity, the park said. The closure is in place between Narada Falls Trail and ...

View post: A Legendary Race Shop Is Still Building 800-HP V10 Engines By Hand Tesla ended production of the Model S sedan and Model X SUV in May 2026. Both models set new standards, enhancing EV ...

S15 - E19 Reunion Part 1 The reunion kicks off with some of the ladies seeking resolution while others remain doubtful following an emotionally charged season. A red-carpet sighting sparks questions ...

The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from insurers. The Centers for Medicare & Medicaid Services first announced the ...